BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND MED12, Q93074, TRAP230, TNRC11, OKS, KIAA0192, HOPA, FGS1, CAGH45, ARC240, 9968
20 results:

  • 1. MIG6 loss confers resistance to ALK/ROS1 inhibitors in NSCLC through EGFR activation by low-dose EGF.
    Kondo N; Utsumi T; Shimizu Y; Takemoto A; Oh-Hara T; Uchibori K; Subat-Motoshi S; Ninomiya H; Takeuchi K; Nishio M; Miyazaki Y; Katayama R
    JCI Insight; 2023 Dec; 8(24):. PubMed ID: 37917191
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Frequently mutated genes in predicting the relapse of stage I lung adenocarcinoma.
    Rao W; Yang L; Dai N; Zhang L; Liu J; Yang B; Li M; Shan J; Wang Q; Wang D
    Clin Transl Oncol; 2023 Jun; 25(6):1767-1778. PubMed ID: 36739576
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Single-cell sequencing reveals novel cellular heterogeneity in uterine leiomyomas.
    Goad J; Rudolph J; Zandigohar M; Tae M; Dai Y; Wei JJ; Bulun SE; Chakravarti D; Rajkovic A
    Hum Reprod; 2022 Sep; 37(10):2334-2349. PubMed ID: 36001050
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. High-grade uterine sarcoma with osteosarcomatous differentiation arising from a med12-mutated leiomyoma, a case report.
    Le MK; Omori M; Oishi N; Oi M; Fukasawa H; Hirata S; Kondo T
    Pathol Int; 2021 Mar; 71(3):199-203. PubMed ID: 33444473
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Association of clinico-genomic characteristics with tumor mutational burden in small cell lung cancer patients.
    Kachroo S; Shao C; Desai K; He J; Jin F; Sen S
    Future Oncol; 2021 Feb; 17(4):423-433. PubMed ID: 33198513
    [No Abstract]    [Full Text] [Related]  

  • 6. Similar results with kinematic and mechanical alignment applied in total knee arthroplasty.
    Luo Z; Zhou K; Peng L; Shang Q; Pei F; Zhou Z
    Knee Surg Sports Traumatol Arthrosc; 2020 Jun; 28(6):1720-1735. PubMed ID: 31250055
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. med12 exerts an emerging role in actin-mediated cytokinesis via LIMK2/cofilin pathway in NSCLC.
    Xu M; Wang F; Li G; Wang X; Fang X; Jin H; Chen Z; Zhang J; Fu L
    Mol Cancer; 2019 May; 18(1):93. PubMed ID: 31072327
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Magnetic Ni/Fe layered double hydroxide nanosheets as enhancer for DNA hairpin sensitive detection of miRNA.
    Sun J; Li Y; Chen C; Qi T; Xia D; Mao W; Yang T; Chen L; Shen W; Tang S
    Talanta; 2018 Sep; 187():265-271. PubMed ID: 29853045
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Multi‑layered prevention and treatment of chronic inflammation, organ fibrosis and cancer associated with canonical WNT/β‑catenin signaling activation (Review).
    Katoh M
    Int J Mol Med; 2018 Aug; 42(2):713-725. PubMed ID: 29786110
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Molecular biomarkers for uterine leiomyosarcoma and endometrial stromal sarcoma.
    Tsuyoshi H; Yoshida Y
    Cancer Sci; 2018 Jun; 109(6):1743-1752. PubMed ID: 29660202
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Clinicopathologic Features and Genetic Alterations of a Primary Osteosarcoma of the Uterine Corpus.
    Zheng G; Richmond A; Liu C; Berrebi A; Pallavajjala A; Haley L; Stone RL; McCarthy E; Vang R; Xing D
    Int J Gynecol Pathol; 2019 Sep; 38(5):414-419. PubMed ID: 29629977
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Deep sequencing reveals the molecular pathology characteristics between primary uterine leiomyoma and pulmonary benign metastasizing leiomyoma.
    Jiang J; He M; Hu X; Ni C; Yang L
    Clin Transl Oncol; 2018 Aug; 20(8):1080-1086. PubMed ID: 29484624
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Recurrent NAB2-STAT6 gene fusions and oestrogen receptor-α expression in pulmonary adenofibromas.
    Fusco N; Guerini-Rocco E; Augello C; Terrasi A; Ercoli G; Fumagalli C; Vacirca D; Braidotti P; Parafioriti A; Jaconi M; Runza L; Ananthanarayanan V; Pagni F; Bosari S; Barberis M; Ferrero S
    Histopathology; 2017 May; 70(6):906-917. PubMed ID: 28072477
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Immunohistochemical profiling of receptor tyrosine kinases, med12, and TGF-βRII of surgically resected small cell lung cancer, and the potential of c-kit as a prognostic marker.
    Yokouchi H; Nishihara H; Harada T; Ishida T; Yamazaki S; Kikuchi H; Oizumi S; Uramoto H; Tanaka F; Harada M; Akie K; Sugaya F; Fujita Y; Takamura K; Kojima T; Higuchi M; Honjo O; Minami Y; Watanabe N; Goto A; Suzuki H; Dosaka-Akita H; Isobe H; Nishimura M; Munakata M
    Oncotarget; 2017 Jun; 8(24):39711-39726. PubMed ID: 28055980
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Comprehensive analysis of the transcriptional profile of the Mediator complex across human cancer types.
    Syring I; Klümper N; Offermann A; Braun M; Deng M; Boehm D; Queisser A; von Mässenhausen A; Brägelmann J; Vogel W; Schmidt D; Majores M; Schindler A; Kristiansen G; Müller SC; Ellinger J; Adler D; Perner S
    Oncotarget; 2016 Apr; 7(17):23043-23055. PubMed ID: 27050271
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. RAS signaling and anti-RAS therapy: lessons learned from genetically engineered mouse models, human cancer cells, and patient-related studies.
    Fang B
    Acta Biochim Biophys Sin (Shanghai); 2016 Jan; 48(1):27-38. PubMed ID: 26350096
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. The quality of life of non-small cell lung cancer patients treated with chemotherapy.
    Karczmarek-Borowska B; Pelc M; Rabiej E; Grądalska-Lampart M
    Pneumonol Alergol Pol; 2014; 82(4):349-57. PubMed ID: 24964238
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Genetics and biomarkers in personalisation of lung cancer treatment.
    Rosell R; Bivona TG; Karachaliou N
    Lancet; 2013 Aug; 382(9893):720-31. PubMed ID: 23972815
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. med12 controls the response to multiple cancer drugs through regulation of TGF-β receptor signaling.
    Huang S; Hölzel M; Knijnenburg T; Schlicker A; Roepman P; McDermott U; Garnett M; Grernrum W; Sun C; Prahallad A; Groenendijk FH; Mittempergher L; Nijkamp W; Neefjes J; Salazar R; Ten Dijke P; Uramoto H; Tanaka F; Beijersbergen RL; Wessels LF; Bernards R
    Cell; 2012 Nov; 151(5):937-50. PubMed ID: 23178117
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Effects of nontoxic heat shock protein 90 inhibitor peptide derivatives on reversal of MDR of tumor cells.
    Molnár J; Engi H; Mándi Y; Somlai C; Penke B; Szabó A; Orosz A
    In Vivo; 2007; 21(2):429-33. PubMed ID: 17436599
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.